“By strengthening our relationships and achieving the right results we make our company more resilient. We want customers to prefer our space. We want communities to be pleased it’s us operating in their area. We want our partners to share our priorities and principles. And we want our employees to feel this is the best place to invest their energy and ambition. Get all of this right and we can sustain Landsec as a strong and respected company for years to come.” Robert Noel, Chief Executive, Landsec
Landsec’s sustainability programme focuses on three key areas:
The 9th Annual Ethical Corporation Responsible Business Awards are back and with the submission deadline set for the 22nd June 2018 time is ticking to enter your submission!
Understanding what it takes to create and drive an innovative strategy can be a challenging task, so to help your submission along, we’ve drawn together a report detailing last year’s winners to demonstrate the projects that win through.
Did you know that 300 years ago people had larger jaws? Why would this be the case and why is it important? Paul Ehrlich, the founding father of modern population sciences, is here to talk about his new book which is a bit of a diversion from his usual work – warning us to not have too many kids. This time, Ehrlich, along with co-author and orthodontist Sandra Kahn, explore the links between jaw size and an increased risk of heart disease, cancer, sleep apnea and hyperactivity.
LOS ANGELES, April 26, 2018 /3BL Media/ - CBRE Group, Inc. (NYSE:CBRE) achieved the highest possible score in IAOP®’s annual assessment of global outsourcing companies for the fourth consecutive year, and again earned its place atop the world’s elite outsourcing firms across all industries.
Caterpillar is dedicated to building a global engineering talent pipeline, critical not only to our continued global growth and competitiveness, but also to the success of our communities. Caterpillar encourages students around the world to pursue STEM careers by investing significantly in STEM programs and initiatives.
Gene therapy has the potential to transform how we manage rare genetic diseases like hemophilia, Duchenne Muscular Dystrophy and others by addressing their root cause – genetic mutations.
The Power of Science behind gene therapy inspires our colleagues, like Bob Smith, SVP, Global Gene Therapy Business, to investigate this groundbreaking technology that could, if successful, bring disease-modification to millions of patients worldwide.